PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,300,000 | -25.9% | 756,675 | +70.8% | 0.02% | -28.6% |
| Q3 2021 | $3,106,000 | +87.0% | 443,081 | +144.9% | 0.02% | +90.9% |
| Q2 2021 | $1,661,000 | -2.2% | 180,944 | +3.6% | 0.01% | -15.4% |
| Q1 2021 | $1,698,000 | +59.9% | 174,693 | +68.7% | 0.01% | +44.4% |
| Q4 2020 | $1,062,000 | +0.7% | 103,528 | -1.0% | 0.01% | -18.2% |
| Q3 2020 | $1,055,000 | -7.0% | 104,543 | -3.8% | 0.01% | -8.3% |
| Q2 2020 | $1,134,000 | +61.1% | 108,689 | +30.3% | 0.01% | +33.3% |
| Q1 2020 | $704,000 | -36.2% | 83,445 | -33.9% | 0.01% | -18.2% |
| Q4 2019 | $1,104,000 | -2.1% | 126,175 | +20.4% | 0.01% | -21.4% |
| Q3 2019 | $1,128,000 | +131.1% | 104,820 | +173.3% | 0.01% | +100.0% |
| Q2 2019 | $488,000 | -71.1% | 38,360 | -12.0% | 0.01% | -70.8% |
| Q1 2019 | $1,690,000 | +373.4% | 43,580 | +148.5% | 0.02% | +300.0% |
| Q4 2018 | $357,000 | +49.4% | 17,540 | +236.7% | 0.01% | +100.0% |
| Q3 2018 | $239,000 | -66.9% | 5,210 | -28.6% | 0.00% | -76.9% |
| Q4 2017 | $721,000 | – | 7,297 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |